Clinical trials
Schizophrenia, Treatment-Resistant trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2017 | 3 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 4 |
| Terminated | 4 |
| Completed | 3 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Azur Pharma, Inc | 1 |
| Boston VA Research Institute, Inc. | 1 |
| Bradley Lega | 1 |
| Daniel Benjamin | 1 |
| H. Lundbeck A/S | 1 |
| Johns Hopkins University | 1 |
| NYU Langone Health | 1 |
| Newron Pharmaceuticals SPA | 1 |
| Ohio State University | 1 |
| SyneuRx International (Taiwan) Corp | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia, Treatment-Resistant | 12 |
| Schizophrenia | 6 |
| Psychotic Disorders | 2 |
| Adenoviridae Infections | 1 |
| Anxiety Disorders | 1 |
| Arrhythmias, Cardiac | 1 |
| Autistic Disorder | 1 |
| Bipolar Disorder | 1 |
| Bradycardia | 1 |
| Central Nervous System Infections | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.